San Diego-based GlySens Inc. has appointed William Markle as the company's new president and CEO.

Markle succeeds founder and current CEO Joseph Lucisano, who will continue to lead the company's development efforts as chief technology officer.

Markle has 25 years of experience in the medical device field and was the founder, president and CEO of GluMetrics Inc. At GluMetrics, he directed the development of continuous real-time sensing technology for intravascular glucose monitoring in the intensive care and operating room environment.

Markle also held senior executive positions in marketing and business development at Tensys Medical and Masimo Corp., and related positions at Baxter Edwards Critical Care and American Hospital Supply.

Markle is an MBA graduate of Pepperdine University and an engineering graduate of Duke University.

GlySens is a privately-held company developing a long-term glucose sensor system to continuously monitor glucose levels and enhance the care and treatment of diabetes.